Bicocca Open Archive

Logo unimib boa
CAZZANIGA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.368
EU - Europa 9.096
AS - Asia 4.986
SA - Sud America 248
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
Totale 35.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.102
SG - Singapore 1.998
IT - Italia 1.903
CN - Cina 1.428
IE - Irlanda 1.377
RU - Federazione Russa 1.318
SE - Svezia 1.272
DE - Germania 1.104
HK - Hong Kong 910
UA - Ucraina 714
GB - Regno Unito 391
CA - Canada 254
FI - Finlandia 224
AT - Austria 205
BR - Brasile 198
FR - Francia 190
VN - Vietnam 165
ID - Indonesia 157
TR - Turchia 103
NL - Olanda 100
IN - India 92
DK - Danimarca 72
BE - Belgio 61
JP - Giappone 34
ES - Italia 33
AR - Argentina 19
BG - Bulgaria 17
CH - Svizzera 16
EU - Europa 16
GR - Grecia 15
IR - Iran 15
CZ - Repubblica Ceca 14
AU - Australia 13
NO - Norvegia 11
PT - Portogallo 11
RO - Romania 11
KR - Corea 10
PL - Polonia 10
EG - Egitto 9
ZA - Sudafrica 8
EC - Ecuador 7
MX - Messico 7
PK - Pakistan 7
CL - Cile 6
IQ - Iraq 6
MU - Mauritius 6
PE - Perù 6
TH - Thailandia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
PH - Filippine 5
VE - Venezuela 5
AZ - Azerbaigian 4
BD - Bangladesh 4
BO - Bolivia 4
EE - Estonia 4
IL - Israele 4
KZ - Kazakistan 4
RE - Reunion 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
BY - Bielorussia 2
CO - Colombia 2
DZ - Algeria 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GL - Groenlandia 1
IM - Isola di Man 1
KE - Kenya 1
LB - Libano 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
OM - Oman 1
PY - Paraguay 1
Totale 35.774
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.634
Fairfield 2.292
Woodbridge 2.114
Houston 1.639
Dublin 1.345
Singapore 1.282
Chandler 1.252
Ashburn 1.148
Wilmington 1.058
Hong Kong 903
Seattle 871
Cambridge 798
Frankfurt am Main 757
Jacksonville 755
Dearborn 605
Milan 546
New York 536
Santa Clara 497
Princeton 492
Lawrence 239
Nanjing 227
Altamura 224
Shanghai 195
Beijing 164
Vienna 164
Jakarta 147
San Diego 147
Lachine 124
Moscow 108
Helsinki 83
Dong Ket 80
Los Angeles 80
Andover 79
Nanchang 77
Lissone 76
Council Bluffs 75
Toronto 71
Guangzhou 66
Shenyang 63
Rome 61
Nuremberg 60
Fuzhou 59
Brussels 57
Hebei 55
Boardman 53
Tianjin 50
London 49
Changsha 48
Jinan 48
Norwalk 41
Chicago 40
Falls Church 34
Jiaxing 32
Ningbo 29
Ottawa 29
Paris 29
Zhengzhou 29
Hangzhou 27
Monza 27
Kunming 26
Besana In Brianza 25
Fremont 25
Pune 25
Redmond 24
Kocaeli 23
Mountain View 23
Turin 23
Como 22
Dallas 20
Huizen 20
São Paulo 20
Bologna 19
Padova 19
Hefei 18
Göttingen 17
San Mateo 17
Florence 16
Munich 16
Cinisello Balsamo 15
Edmonton 13
Grafing 13
Seregno 13
Sesto San Giovanni 13
Taizhou 13
Carate Brianza 12
Naples 12
Athens 11
Bergamo 11
Brugherio 11
Nürnberg 11
Washington 11
Hounslow 10
Lappeenranta 10
Mumbai 10
Perugia 10
Phoenix 10
Romola 10
Verona 10
Chengdu 9
Leawood 9
Totale 26.515
Salva come PNG Salva come JPEG
Nome #
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 364
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 330
NIPBL: a new player in myeloid cells differentiation 321
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 316
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 298
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 293
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 285
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 282
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 278
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 275
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 266
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 263
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 260
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 258
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 245
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 243
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 229
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 227
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 223
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 221
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 217
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 213
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 213
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 209
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 209
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 205
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 202
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 202
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 202
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 200
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 200
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 199
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 199
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 196
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 195
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 195
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 194
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 191
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 191
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 190
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts 189
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 189
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 189
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 187
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 187
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 187
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 185
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 185
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 183
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 182
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 181
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 180
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 180
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia 180
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 180
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 178
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 177
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 175
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 174
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 173
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol 173
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 172
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 171
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 171
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study 170
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 170
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 169
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis 168
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome 168
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 168
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 168
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations 167
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study 167
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 166
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 166
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 166
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias 165
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 164
TEL/ARG induces cytoskeletal abnormalities in 293T cells 163
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 163
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia 162
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 162
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells 162
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 161
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 161
Predictive factors of relapse and survival in childhood acute myeloid leukemia: Role of minimal residual disease 161
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: Revisited in AIEOP-BFM protocol 161
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 160
Metabolic gatekeeper function of B-lymphoid transcription factors 160
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 157
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 156
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 155
Novel activating mutations lacking cysteine in type i cytokine receptors in acute lymphoblastic leukemia 154
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia 154
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 154
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 154
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 153
T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses 153
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 152
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 150
Totale 19.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020817 0 0 0 0 0 0 0 0 0 343 317 157
2020/20215.491 222 341 432 474 446 436 816 678 399 494 350 403
2021/20223.278 232 342 419 237 256 271 123 177 208 230 227 556
2022/20235.119 663 1.625 374 426 282 793 67 292 332 31 154 80
2023/20244.081 119 130 173 185 528 1.087 816 152 357 85 81 368
2024/20256.464 466 1.067 552 447 866 311 662 292 1.069 732 0 0
Totale 36.966